Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 11.17 CAD -2.45% Market Closed
Market Cap: 4.1B CAD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bausch Health Companies Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Bausch Health Companies Inc
TSX:BHC
Free Cash Flow
$1B
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Sundial Growers Inc
NASDAQ:SNDL
Free Cash Flow
-CA$24.6m
CAGR 3-Years
26%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Free Cash Flow
$12.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Free Cash Flow
-$74.3m
CAGR 3-Years
-18%
CAGR 5-Years
-170%
CAGR 10-Years
-94%
K
Knight Therapeutics Inc
TSX:GUD
Free Cash Flow
CA$20.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Free Cash Flow
-$33.1m
CAGR 3-Years
33%
CAGR 5-Years
-149%
CAGR 10-Years
N/A
No Stocks Found

Bausch Health Companies Inc
Glance View

Market Cap
4.1B CAD
Industry
Pharmaceuticals

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 19,600 full-time employees. The firm is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

BHC Intrinsic Value
111.31 CAD
Undervaluation 90%
Intrinsic Value
Price

See Also

What is Bausch Health Companies Inc's Free Cash Flow?
Free Cash Flow
1B USD

Based on the financial report for Sep 30, 2024, Bausch Health Companies Inc's Free Cash Flow amounts to 1B USD.

What is Bausch Health Companies Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-3%

Over the last year, the Free Cash Flow growth was 13%. The average annual Free Cash Flow growth rates for Bausch Health Companies Inc have been -13% over the past three years , -5% over the past five years , and -3% over the past ten years .

Back to Top